| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.11 | 0.6 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | QL-XI-92 | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.095 | 0.6 |
| mRNA | PF-562271 | GDSC1000 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | Mitomycin-C | GDSC1000 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.017 | 0.6 |